Vista Investment Partners LLC Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Vista Investment Partners LLC grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,463 shares of the company’s stock after purchasing an additional 230 shares during the quarter. Vista Investment Partners LLC’s holdings in HCA Healthcare were worth $2,540,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare in the 2nd quarter worth $33,000. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP bought a new position in HCA Healthcare during the 3rd quarter worth approximately $41,000. Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new position in shares of HCA Healthcare in the third quarter worth $44,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 4.0 %

Shares of HCA stock opened at $312.51 on Friday. The firm’s 50 day moving average is $313.49 and its 200 day moving average is $352.62. The stock has a market capitalization of $79.16 billion, a P/E ratio of 14.03, a P/E/G ratio of 1.09 and a beta of 1.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12-month low of $279.93 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period in the prior year, the business earned $5.90 EPS. Research analysts expect that HCA Healthcare, Inc. will post 21.75 earnings per share for the current year.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on HCA shares. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.27.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.